Vesiculopustular dermatosis: An uncommon side-effect of liraglutide?
Author:
Publisher
Elsevier BV
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference11 articles.
1. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6);Buse;The Lancet,2009
2. Liraglutide treatment is associated with a low frequency and magnitude of antibody formation with no apparent impact on glycemic response or increased frequency of adverse events: results from the Liraglutide Effect and Action in Diabetes (LEAD) trials;Buse;The Journal of Clinical Endocrinology and Metabolism,2011
3. Enhancing incretin action for the treatment of type 2 diabetes;Drucker;Diabetes Care,2003
4. Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial;Garber;The Lancet,2009
5. Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with type 2 diabetes (LEAD-1 SU);Marre;Diabetic Medicine,2009
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cutaneous hypersensitivity reaction to dulaglutide: A case report of an allergic reaction;Diabetes & Metabolism;2024-09
2. Rare Liraglutide-Induced Dermatological Adverse Reaction in the Treatment of Obesity;Journal of Diabetes and Endocrine Practice;2024-07
3. Hypersensitivity to liraglutide: A case report;Asia Pacific Allergy;2024-06-17
4. Rare cutaneous adverse reactions associated with GLP-1 agonists: a review of the published literature;Archives of Dermatological Research;2024-05-25
5. Delayed Type Hypersensitivity Reaction Induced By Liraglutide With Tolerance to Semaglutide;JCEM Case Reports;2024-05-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3